Personalised medicine is an emerging field that uses an individual's genetic information to tailor medical treatment to their specific needs.

​

This approach has the potential to significantly impact the future of healthcare in several ways:

• Improved patient outcomes: Personalised medicine can lead to more effective treatments, since medical interventions will be based on the individual's genetic profile, rather than a one-size-fits-all approach.

• Reduced side effects: Personalised medicine can help minimise side effects from drugs, since treatments will be based on a patient's specific genetic makeup.

• Increased efficiency: Personalised medicine can also improve the efficiency of the healthcare system by reducing the trial and error approach to treatment, which can save time and resources.

• New therapeutic avenues: Personalised medicine may also lead to the development of new drugs and treatments that are specifically targeted to an individual's genetic makeup.

• More targeted clinical trials: Personalised medicine can also help to design more targeted clinical trials, which can lead to faster and more accurate results.

In addition to genetic-based personalised medicine, there are several other forms of personalised medication, including:

• Phenotypic personalised medicine: This approach uses a patient's clinical and demographic information, such as age, gender, medical history, and lifestyle, to determine the best treatment plan.

• Biomarker-based personalised medicine: This approach uses specific biological markers, such as proteins or gene expressions, to identify the most appropriate treatment for a patient.

• Radiomics-based personalised medicine: This approach uses imaging technologies, such as MRI or CT scans, to develop a patient-specific profile, which can be used to guide treatment decisions.

• Microbiome-based personalised medicine: This approach considers the patient's microbiome, the collection of microorganisms that live within the body, to guide treatment decisions.

• Machine learning-based personalised medicine: This approach uses artificial intelligence and machine learning algorithms to analyse patient data and predict the best treatment options.

Stem cells have the potential to be used as a form of personalised medicine, as they can be harvested from a patient's own body and used to replace damaged or diseased cells, tissues, and organs. This approach offers several potential benefits, including:

• Improved patient outcomes: Stem cell therapies have the potential to treat a wide range of diseases and conditions, including heart disease, diabetes, and certain types of cancer, which can lead to improved patient outcomes.

• Reduced side effects: Since stem cells are harvested from a patient's own body, there is a reduced risk of immune rejection, which can minimise side effects.

• Increased efficiency: Stem cell therapies can also improve the efficiency of the healthcare system, as they can provide long-lasting benefits and reduce the need for repeated treatments.

• New therapeutic avenues: Stem cell research is also opening up new therapeutic avenues, as scientists explore the potential of stem cells to treat conditions that were previously considered untreatable.

Personalised medicine, while offering many benefits, also faces several limitations, including:

• Cost: Personalised medicine can be expensive, as it often involves advanced technologies and specialised testing, which can increase the cost of healthcare.

• Access to technology: Personalised medicine relies on advanced technologies, such as genetic sequencing and imaging, which may not be widely available, particularly in low- and middle-income countries.

• Limited data: Personalised medicine requires large amounts of data, including patient information, genetic information, and medical records, which may not always be available or accurate.

• Ethical concerns: Personalised medicine raises ethical concerns, such as privacy, discrimination, and informed consent, which need to be carefully considered and addressed.

• Lack of standardisation: Personalised medicine is a rapidly evolving field, and there is a lack of standardisation in terms of testing, data interpretation, and treatment recommendations, which can lead to inconsistent results and confusion.

• Reimbursement: Personalised medicine may not be fully covered by insurance, and the reimbursement process can be complex, which can create barriers to access.

In conclusion, there are several forms of personalised medicine that go beyond genetics, including phenotypic, biomarker-based, radiomics-based, microbiome-based, and machine learning-based personalised medicine, each of which offers unique benefits and opportunities for improved patient outcomes. Personalised medicine has the potential to significantly impact the future of healthcare by reducing side effects, increasing efficiency, and opening up new therapeutic avenues. 

However, while personalised medicine offers many benefits, it is also subject to several limitations, including cost, access to technology, limited data, ethical concerns, lack of standardisation, and reimbursement issues, which must be carefully considered and addressed. 

While personalised medicine is a rapidly evolving field, further research and development is needed to fully realise its true potential.

The Mantell Associates Cell & Gene Therapy division specialise within viral-vector gene therapies, and are well positioned to help you grow your team or find your next opportunity. Get in touch with Huseyin Pulat at huseyin.pulat@mantellassociates.com. 

​